AK

Atul Kisanrao Girme

Active Director Director DIN 07523028
DIN 07523028 First appointment May 2016 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2016
Shareholding value •••• Premium profile

About Atul Kisanrao Girme

Data last updated:

Atul Kisanrao Girme is a Director at Rich Pharma India Private Limited (since 2016). The company operates in Pharma. Rich Pharma India Private Limited reported revenue of ₹5.10 Cr (FY 2016).

DIN 07523028
Primary Designation Director
Industry Pharma
First Appointment 20 May 2016
Oldest Company Age 18 yrs
Largest company Rich Pharma India Private Limited · ₹5.10 Cr (FY 2016)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Rich Pharma India Private Limited U24239PN2008PTC131753
Director20 May 20162008₹5.10 Cr (FY 2016)Active

Board colleagues of Atul Kisanrao Girme

Directorship timeline

Open interactive timeline →
Rich Pharma India Private Limited
Premium access

Shareholding and investment profile for Atul Kisanrao Girme

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Atul Kisanrao Girme

Atul Kisanrao Girme currently holds 1 directorship: Rich Pharma India Private Limited (Director, since 20 May 2016, revenue ₹5.10 Cr (FY 2016)).

Atul Kisanrao Girme was first appointed on 20 May 2016 as Director at Rich Pharma India Private Limited.

The current boards of Atul Kisanrao Girme's companies include Jayashree Vasant Gawade (Rich Pharma India Private Limited), Rohit Sudesh Girme (Rich Pharma India Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available